Deutsche Bank’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.54M | Buy |
143,037
+6,552
| +5% | +$179K | ﹤0.01% | 1342 |
|
|
2025
Q4 | $3.71M | Buy |
136,485
+1,928
| +1% | +$50.8K | ﹤0.01% | 1457 |
|
|
2025
Q3 | $3.48M | Buy |
134,557
+5,976
| +5% | +$138K | ﹤0.01% | 1474 |
|
|
2025
Q2 | $2.62M | Sell |
128,581
-9,708
| -7% | -$189K | ﹤0.01% | 1547 |
|
|
2025
Q1 | $2.51M | Buy |
138,289
+16,788
| +14% | +$375K | ﹤0.01% | 1604 |
|
|
2024
Q4 | $3.07M | Buy |
121,501
+82,042
| +208% | +$2.23M | ﹤0.01% | 1587 |
|
|
2024
Q3 | $1.34M | Sell |
39,459
-5,024
| -11% | -$191K | ﹤0.01% | 1983 |
|
|
2024
Q2 | $1.65M | Sell |
44,483
-1,409
| -3% | -$53.2K | ﹤0.01% | 1729 |
|
|
2024
Q1 | $1.93M | Buy |
45,892
+9,577
| +26% | +$393K | ﹤0.01% | 1680 |
|
|
2023
Q4 | $1.44M | Sell |
36,315
-906
| -2% | -$26.6K | ﹤0.01% | 1842 |
|
|
2023
Q3 | $1.02M | Buy |
37,221
+3,213
| +9% | +$101K | ﹤0.01% | 1708 |
|
|
2023
Q2 | $1.15M | Sell |
34,008
-11,120
| -25% | -$375K | ﹤0.01% | 1910 |
|
|
2023
Q1 | $1.62M | Buy |
45,128
+8,805
| +24% | +$380K | ﹤0.01% | 1802 |
|
|
2022
Q4 | $1.62M | Buy |
36,323
+2,811
| +8% | +$100K | ﹤0.01% | 1769 |
|
|
2022
Q3 | $942K | Sell |
33,512
-136,702
| -80% | -$4.19M | ﹤0.01% | 2009 |
|
|
2022
Q2 | $4.59M | Buy |
170,214
+95,357
| +127% | +$2.77M | ﹤0.01% | 1328 |
|
|
2022
Q1 | $2.55M | Sell |
74,857
-23,039
| -24% | -$736K | ﹤0.01% | 1753 |
|
|
2021
Q4 | $3.78M | Buy |
97,896
+52,637
| +116% | +$2.29M | ﹤0.01% | 1606 |
|
|
2021
Q3 | $2.44M | Buy |
45,259
+10,628
| +31% | +$499K | ﹤0.01% | 1948 |
|
|
2021
Q2 | $1.16M | Buy |
34,631
+32,223
| +1,338% | +$885K | ﹤0.01% | 2680 |
|
|
2021
Q1 | $50K | Sell |
2,408
-79,824
| -97% | -$1.83M | ﹤0.01% | 4236 |
|
|
2020
Q4 | $1.44M | Sell |
82,232
-312,041
| -79% | -$5.62M | ﹤0.01% | 2174 |
|
|
2020
Q3 | $5.85M | Buy |
+394,273
| New | +$4.62M | ﹤0.01% | 1195 |
|
|
2019
Q1 | – | Sell |
-84,546
| Closed | -$250K | – | 5198 |
|
|
2018
Q4 | $250K | Sell |
84,546
-47,542
| -36% | -$233K | ﹤0.01% | 3753 |
|
|
2018
Q3 | $893K | Sell |
132,088
-42,689
| -24% | -$299K | ﹤0.01% | 3414 |
|
|
2018
Q2 | $1.32M | Buy |
174,777
+122,437
| +234% | +$1.64M | ﹤0.01% | 3240 |
|
|
2018
Q1 | $1.83M | Buy |
52,340
+5,572
| +12% | +$216K | ﹤0.01% | 2926 |
|
|
2017
Q4 | $1.99M | Sell |
46,768
-18,822
| -29% | -$806K | ﹤0.01% | 2728 |
|
|
2017
Q3 | $2.81M | Sell |
65,590
-27,112
| -29% | -$1.02M | ﹤0.01% | 2315 |
|
|
2017
Q2 | $3.43M | Sell |
92,702
-54,843
| -37% | -$2.43M | ﹤0.01% | 2184 |
|
|
2017
Q1 | $7.99M | Buy |
147,545
+26,090
| +21% | +$1.36M | 0.01% | 1399 |
|
|
2016
Q4 | $6.45M | Sell |
121,455
-44,513
| -27% | -$2.53M | 0.01% | 1522 |
|
|
2016
Q3 | $10.1M | Sell |
165,968
-37,518
| -18% | -$2.34M | 0.01% | 1305 |
|
|
2016
Q2 | $13.4M | Buy |
203,486
+110,188
| +118% | +$7M | 0.01% | 1127 |
|
|
2016
Q1 | $5.29M | Buy |
93,298
+46,496
| +99% | +$5.23M | ﹤0.01% | 1689 |
|
|
2015
Q4 | $11M | Sell |
46,802
-47,984
| -51% | -$10.5M | 0.01% | 1257 |
|
|
2015
Q3 | $15M | Buy |
94,786
+5,686
| +6% | +$1.61M | 0.01% | 1059 |
|
|
2015
Q2 | $33.7M | Sell |
89,100
-1,147
| -1% | -$456K | 0.02% | 698 |
|
|
2015
Q1 | $37.7M | Buy |
90,247
+59,919
| +198% | +$21.4M | 0.02% | 645 |
|
|
2014
Q4 | $8.3M | Buy |
30,328
+5,514
| +22% | +$1.37M | 0.01% | 1565 |
|
|
2014
Q3 | $4.82M | Sell |
24,814
-6,474
| -21% | -$1.41M | ﹤0.01% | 1863 |
|
|
2014
Q2 | $7.66M | Sell |
31,288
-1,270
| -4% | -$287K | 0.01% | 1525 |
|
|
2014
Q1 | $8.63M | Buy |
32,558
+5,390
| +20% | +$2.06M | 0.01% | 1434 |
|
|
2013
Q4 | $9.86M | Sell |
27,168
-25,787
| -49% | -$9.93M | 0.01% | 1348 |
|
|
2013
Q3 | $28.1M | Buy |
52,955
+33,445
| +171% | +$11.5M | 0.02% | 729 |
|
|
2013
Q2 | $4.57M | Buy |
+19,510
| New | +$3.84M | ﹤0.01% | 1671 |
|
Other funds holding CLDX
KCM
VCM
CC
EP